A study to estimate the effect of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects.
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2009
At a glance
- Drugs Nelfinavir (Primary) ; Omeprazole
- Indications Gastrointestinal disorders; HIV infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 13 Feb 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 13 Feb 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov, last updated 13-Feb-2009.
- 28 Aug 2006 Status change